Explore
Validate
Learn
Western blotAntibody data
- Antibody Data
- Antigen structure
- References [6]
- Comments [0]
- Validations [0]
Submit
Validation data
Reference
Comment
Report error
- Product number
- ABIN265170 - Provider product page
- Provider
- antibodies-online
- Product name
- anti-Four and A Half LIM Domains 2 (FHL2) antibody
- Antibody type
- Polyclonal
- Antigen
- Synthetic peptide derived from the human FHL2 protein
- Description
- Affinity chromatography
- Reactivity
- Human
- Host
- Rabbit
- Isotype
- IgG
- Vial size
- 50 μg
- Storage
- Ship on dry ice. Upon arrival, freeze in aliquots az -20°C to -70°C.
- Handling
- Avoid repeated freezing and thawing.
Submitted references Genetic analysis of anterior posterior expression gradients in the developing mammalian forebrain.
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.
FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
Kudo LC, Karsten SL, Chen J, Levitt P, Geschwind DH
Cerebral cortex (New York, N.Y. : 1991) 2007 Sep;17(9):2108-22
Cerebral cortex (New York, N.Y. : 1991) 2007 Sep;17(9):2108-22
Proline-, glutamic acid-, and leucine-rich protein-1/modulator of nongenomic activity of estrogen receptor enhances androgen receptor functions through LIM-only coactivator, four-and-a-half LIM-only protein 2.
Nair SS, Guo Z, Mueller JM, Koochekpour S, Qiu Y, Tekmal RR, Schüle R, Kung HJ, Kumar R, Vadlamudi RK
Molecular endocrinology (Baltimore, Md.) 2007 Mar;21(3):613-24
Molecular endocrinology (Baltimore, Md.) 2007 Mar;21(3):613-24
Identification of the FHL2 transcriptional coactivator as a new functional target of the E7 oncoprotein of human papillomavirus type 16.
Campo-Fernández B, Morandell D, Santer FR, Zwerschke W, Jansen-Dürr P
Journal of virology 2007 Jan;81(2):1027-32
Journal of virology 2007 Jan;81(2):1027-32
FHL2/SLIM3 decreases cardiomyocyte survival by inhibitory interaction with sphingosine kinase-1.
Sun J, Yan G, Ren A, You B, Liao JK
Circulation research 2006 Sep 1;99(5):468-76
Circulation research 2006 Sep 1;99(5):468-76
Androgen receptor coactivators lysine-specific histone demethylase 1 and four and a half LIM domain protein 2 predict risk of prostate cancer recurrence.
Kahl P, Gullotti L, Heukamp LC, Wolf S, Friedrichs N, Vorreuther R, Solleder G, Bastian PJ, Ellinger J, Metzger E, Schüle R, Buettner R
Cancer research 2006 Dec 1;66(23):11341-7
Cancer research 2006 Dec 1;66(23):11341-7
Disruption of four-and-a-half LIM 2 decreases bone mineral content and bone mineral density in femur and tibia bones of female mice.
Govoni KE, Baylink DJ, Chen J, Mohan S
Calcified tissue international 2006 Aug;79(2):112-7
Calcified tissue international 2006 Aug;79(2):112-7
No comments: Submit comment
No validations: Submit validation data